Carboplatin

You have access
Silibinin Administration Improves Hepatic Failure Due to Extensive Liver Infiltration in a Breast Cancer Patient
JOAQUIM BOSCH-BARRERA, BRUNA COROMINAS-FAJA, ELISABET CUYÀS, BEGOÑA MARTIN-CASTILLO, JOAN BRUNET and JAVIER A. MENENDEZ

Anticancer Research August 2014, 34 (8) 4323-4327;
You have access
Chemotherapy for Advanced Endometrial Cancer with Carboplatin and Epirubicin
SYED HAMMAD TIRMAZY, URMILA BARTHAKUR, AHMED EL-MODIR, SUHAIL ANWAR and INDRAJIT FERNANDO

Anticancer Research July 2014, 34 (7) 3793-3798;
You have access
‘BRCAness’ and Its Implications for Platinum Action in Gynecologic Cancer
FRANCO MUGGIA and TAMAR SAFRA

Anticancer Research February 2014, 34 (2) 551-556;
You have access
Bevacizumab plus Weekly Paclitaxel with or Without Carboplatin for Previously-treated Non-squamous Non-Small Cell Lung Cancer
AKITO HATA, NOBUYUKI KATAKAMI, KOSUKE TANAKA, JUMPEI TAKESHITA, TAKESHI MATSUMOTO, KAZUYA MONDEN, KAZUMA NAGATA, KATSUHIRO MASAGO, REIKO KAJI, SHIRO FUJITA, RYO TACHIKAWA, KYOKO OTSUKA, KOJIRO OTSUKA and KEISUKE TOMII

Anticancer Research January 2014, 34 (1) 275-281;
You have access
Phase II trial of Pemetrexed Continuation – Maintenance after Carboplatin-based Induction in Untreated Non-squamous Non-small Cell Lung Cancer
SEIGO MINAMI, TAKASHI KIJIMA, KIYOSHI KOMUTA, TORU KUMAGAI, FUMIO IMAMURA, SOICHIRO YOKOTA, YOSHIKO TAKEUCHI, TAKESHI NAKATANI, ISAO TACHIBANA and ICHIRO KAWASE

Anticancer Research December 2013, 33 (12) 5535-5542;
You have access
Prevention of Carboplatin-induced Resistance in Human Ovarian Tumor Xenografts by Selenite
PAULA B. CAFFREY and GERALD D. FRENKEL

Anticancer Research October 2013, 33 (10) 4249-4254;
You have access
Phase I Trial of Carboplatin and Etoposide in Combination with Panobinostat in Patients with Lung Cancer
AHMAD A. TARHINI, HARIS ZAHOOR, BRIAN MCLAUGHLIN, WILLIAM E GOODING, JOHN C. SCHMITZ, JILL M. SIEGFRIED, MARK A. SOCINSKI and ATHANASSIOS ARGIRIS

Anticancer Research October 2013, 33 (10) 4475-4481;
You have access
Progression-free Survival Is Accurately Predicted in Patients Treated with Chemotherapy for Epithelial Ovarian Cancer by the Histoculture Drug Response Assay in a Prospective Correlative Clinical Trial at a Single Institution
PHILL-SEUNG JUNG, DAE-YEON KIM, MOON-BO KIM, SHIN-WHA LEE, JONG-HYEOK KIM, YONG-MAN KIM, YOUNG-TAK KIM, ROBERT M. HOFFMAN and JOO-HYUN NAM

Anticancer Research March 2013, 33 (3) 1029-1034;
You have access
Phase II Study of Carboplatin and Weekly Irinotecan Combination Chemotherapy in Recurrent Ovarian Cancer: A Kansai Clinical Oncology Group Study (KCOG0330)
HIROSHI TSUBAMOTO, RYUJI KAWAGUCHI, KIMIHIKO ITO, TAKAYA SHIOZAKI, SATOSHI TAKEUCHI, YOSHIO ITANI, ATSUSHI ARAKAWA, TSUTOMU TABATA and SHINJI TOYODA

Anticancer Research March 2013, 33 (3) 1073-1079;
You have access
Safety and Efficacy of Platinum Agents plus Etoposide for Patients with Small Cell Lung Cancer with Interstitial Lung Disease
TATSUYA YOSHIDA, KIYOTAKA YOH, KOICHI GOTO, SEIJI NIHO, SHIGEKI UMEMURA, HIRONOBU OHMATSU and YUICHIRO OHE

Anticancer Research March 2013, 33 (3) 1175-1179;

Main menu

User menu

Search

Carboplatin

Pages